Search Results - "Nachtigall, Lila E."

The Women's Health Initiative trial and related studies: 10 years later: A clinician's view by Gurney, Elizabeth P., Nachtigall, Margaret J., Nachtigall, Lila E., Naftolin, Frederick

“…•10 years after the WHI, new data is changing clinical menopause management.•Hormone therapy is safe in carefully screened perimenopausal women.•Estrogen and…”
Get full text

Work stress and menopausal symptoms by Nachtigall, Lila E

Get full text

Menopause and the gastrointestinal system: our gut feelings by Nachtigall, Lila E, Nachtigall, Lisa

Get full text

Therapy Nonhormonal treatment of hot flashes-a viable alternative? by Nachtigall, Lila E

“…A new study published in the Journal of Clinical Oncology has ascertained the efficacy of selective serotonin-reuptake inhibitors, serotonin and norepinephrine…”
Get full text

Nonhormonal treatment of hot flashes—a viable alternative? by Nachtigall, Lila E.

“…A new study published in the Journal of Clinical Oncology has ascertained the efficacy of selective serotonin-reuptake inhibitors, serotonin and norepinephrine…”
Get full text

Screening the postmenopausal ovary by Nachtigall, Lila E.

Get full text

The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition by Naftolin, Frederick, Taylor, Hugh S, Karas, Richard, Brinton, Eliot, Newman, Isadore, Clarkson, Thomas B, Mendelsohn, Michael, Lobo, Rogerio A, Judelson, Debra R, Nachtigall, Lila E, Heward, Christopher B, Hecht, Harvey, Jaff, Michael R, Harman, S Mitchell

“…The Women's Health Initiative (WHI) randomized controlled trial failed to show cardioprotection by estrogen plus progestin treatment of postmenopausal women…”
Get more information

Breast density as a clinical entity: is it a marker for breast cancer? by Nachtigall, Lila E.

Get full text

The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women by Nachtigall, Margaret J., Jessel, Rebecca H., Flaumenhaft, Robert, Nachtigall, Richard, Yoles, Israel, Naftolin, Frederick, Nachtigall, Lila E.

“…OBJECTIVE:The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on platelet function in normal and…”
Get full text

Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach by Nachtigall, Lila E, Baber, Rodney J, Barentsen, Ronald, Durand, Nancy, Panay, Nick, Pitkin, Joan, van de Weijer, Peter H M, Wysocki, Susan

“…Vasomotor symptoms are the most common menopausal symptom experienced by women and the leading reason menopausal women seek health care advice. The recent…”
Get more information

Menopause and the gastrointestinal system: our gut feelings by Nachtigall, Lila E., Nachtigall, Lisa

Get full text

The 2017 hormone therapy position statement of The North American Menopause Society

“…ABSTRACTThe 2017 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The…”
Get full text

Menopausal Changes, Quality of Life, and Hormone Therapy by NACHTIGALL, LILA E, NACHTIGALL, MARGARET J

Get full text

The Symptoms of Perimenopause by NACHTIGALL, LILA E

Get full text

Letter to the Editor by Nachtigall, Margaret J., Nachtigall, Lila E., Nachtigall, Richard H.

Get full text

Letter to the Editor by Nachtigall, Margaret J., Nachtigall, Lila E., Nachtigall, Richard H.

Get full text

To the Editor by Nachtigall, Margaret J., Nachtigall, Lila E., Nachtigall, Richard H.

Get full text

Letter to the Editor by Nachtigall, Margaret J, Nachtigall, Lila E, Nachtigall, Richard H

Get full text

Is Percentile Body Fat by Dual-Energy X-Ray Absorptiometry a Better Surrogate for Metabolic Health Than Body Mass Index? [308] by Goldstein, Steven Robert, Nachtigall, Lila E., Nachtigall, Richard

Get full text

Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy by Nachtigall, M J, Smilen, S W, Nachtigall, R D, Nachtigall, R H, Nachtigall, L E

“…To review the incidence of breast cancer in a continuous 22-year study of conjugated estrogen-medroxyprogesterone acetate hormone replacement therapy…”
Get more information